Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00397878
What this trial is testing

AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT03706235
What this trial is testing

Colvera for Detection of Disease Recurrence

Who this might be right for
Colorectal Adenocarcinoma
Clinical Genomics Pathology 488
Testing effectiveness (Phase 2)Ended earlyNCT00541112
What this trial is testing

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Who this might be right for
Colorectal Cancer
UNICANCER 19
Large-scale testing (Phase 3)Study completedNCT00064181
What this trial is testing

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 86
Testing effectiveness (Phase 2)Looking for participantsNCT07589517
What this trial is testing

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal AdenocarcinomaUnresectable Colorectal Cancer
Beijing Biotech 48
Testing effectiveness (Phase 2)Study completedNCT04457284
What this trial is testing

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Who this might be right for
Colorectal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)Study completedNCT00753415
What this trial is testing

V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Who this might be right for
Non-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more
Merck Sharp & Dohme LLC 37
Early research (Phase 1)Looking for participantsNCT03715933
What this trial is testing

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Who this might be right for
Ewing SarcomaColorectal Adenocarcinoma
Inhibrx Biosciences, Inc 411
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Looking for participantsNCT07529808
What this trial is testing

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more
BigHat Biosciences, Inc. 164
Early research (Phase 1)Not Yet RecruitingNCT07715903
What this trial is testing

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy

Who this might be right for
Colorectal NeoplasmsNeoplasmsIntrahepatic Cholangiocarcinoma+2 more
National Cancer Institute (NCI) 20
Very early researchWithdrawnNCT01403103
What this trial is testing

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT00005833
What this trial is testing

S9923 R115777 in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 62
Not applicableNot Yet RecruitingNCT07341126
What this trial is testing

Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal

Who this might be right for
Bowel CancerPolyp RectalRectal Cancer+2 more
University of Edinburgh 30
Not applicableStudy completedNCT04898842
What this trial is testing

Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+8 more
Royal Surrey County Hospital NHS Foundation Trust 30
Not applicableStudy completedNCT00940030
What this trial is testing

Comparison of Mechanical Bowel Preparation Versus Enema for Candidates to Colorectal Resection for Adenocarcinoma

Who this might be right for
Colorectal Cancer
European Institute of Oncology 440
Not applicableStudy completedNCT00417040
What this trial is testing

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Who this might be right for
Prostate CancerBreast CancerLung Cancer+3 more
Alliance for Clinical Trials in Oncology 325
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Next Page